Dragonetti, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 1.022
AS - Asia 960
EU - Europa 559
SA - Sud America 208
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 2.780
Nazione #
US - Stati Uniti d'America 992
SG - Singapore 479
BR - Brasile 178
CN - Cina 171
SE - Svezia 106
DE - Germania 99
FR - Francia 94
VN - Vietnam 81
IT - Italia 76
IN - India 64
IE - Irlanda 42
GB - Regno Unito 35
ID - Indonesia 29
JP - Giappone 27
RU - Federazione Russa 23
FI - Finlandia 17
HK - Hong Kong 15
KR - Corea 15
BD - Bangladesh 14
MX - Messico 14
AT - Austria 13
IQ - Iraq 12
PL - Polonia 11
ZA - Sudafrica 11
CA - Canada 10
AR - Argentina 9
TR - Turchia 9
ES - Italia 8
NL - Olanda 8
PK - Pakistan 7
VE - Venezuela 5
CH - Svizzera 4
CO - Colombia 4
EC - Ecuador 4
EG - Egitto 4
MA - Marocco 4
UA - Ucraina 4
AZ - Azerbaigian 3
BE - Belgio 3
CZ - Repubblica Ceca 3
IL - Israele 3
JO - Giordania 3
KZ - Kazakistan 3
MY - Malesia 3
NP - Nepal 3
PY - Paraguay 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
DK - Danimarca 2
DZ - Algeria 2
EU - Europa 2
GT - Guatemala 2
KE - Kenya 2
KW - Kuwait 2
PE - Perù 2
PH - Filippine 2
TW - Taiwan 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MN - Mongolia 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
ZM - Zambia 1
ZW - Zimbabwe 1
Totale 2.780
Città #
Singapore 270
Ashburn 134
Chandler 134
San Jose 115
Dublin 42
Beijing 40
Hyderabad 35
Ho Chi Minh City 34
Munich 34
The Dalles 34
Chicago 33
Hefei 33
New York 32
Los Angeles 30
Jakarta 28
Tokyo 26
Frankfurt am Main 24
Lauterbourg 24
Milan 21
Marseille 19
Santa Clara 17
Hanoi 16
Rome 16
Boston 15
Hong Kong 15
Nuremberg 15
Bremen 14
Dallas 14
Princeton 14
St Louis 14
San Mateo 13
Seoul 13
São Paulo 13
Washington 13
Moscow 11
Orem 11
Kent 10
Council Bluffs 9
Poplar 9
Chennai 8
Denver 8
Helsinki 8
Brasília 7
London 7
Paris 7
Roubaix 7
Wilmington 7
Johannesburg 6
Dhaka 5
Düsseldorf 5
Mexico City 5
Portsmouth 5
Rio de Janeiro 5
Turku 5
Vienna 5
Warsaw 5
Amsterdam 4
Ann Arbor 4
Baghdad 4
Brooklyn 4
Buffalo 4
Falls Church 4
Jiaxing 4
Lappeenranta 4
Mumbai 4
North Bergen 4
Pune 4
Shanghai 4
Toronto 4
Wroclaw 4
Amman 3
Ankara 3
Atlanta 3
Brno 3
Brussels 3
Busto Arsizio 3
Cattolica 3
City of London 3
Dearborn 3
Fortaleza 3
Guarulhos 3
Haiphong 3
Hải Dương 3
Kuala Lumpur 3
Lahore 3
Manchester 3
Montreal 3
Nanjing 3
Perugia 3
Phoenix 3
Querétaro 3
Seattle 3
Valladolid 3
Almaty 2
Anápolis 2
Aracaju 2
Augusta 2
Baku 2
Bauru 2
Belo Horizonte 2
Totale 1.638
Nome #
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 152
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 146
Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis 143
Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016-B survey 142
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) 131
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA) 118
Developments in identifying and managing mucormycosis in hematologic cancer patients 117
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings 116
Disseminated geosmithia argillacea infection in a patient with ph-positive acute lymphoblastic leukemia. Case report and literature review 115
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey 112
Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016-B survey 108
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry 107
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA 102
Pharyngeal microbial signatures are predictive of the risk of fungal pneumonia in hematologic patients 98
Impact of invasive aspergillosis occurring during first induction therapy on outcome of acute myeloid leukaemia (SEIFEM-12B study) 97
Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report 96
A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants 95
'Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study 93
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey 93
Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax 86
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry 84
SARS-CoV-2 Infection In Patients With Mastocytosis: An EPICOVIDEHA Report 83
Rhodotorula infection in haematological patient: Risk factors and outcome 83
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry 82
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey 79
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey 75
Rhodotorula infection in haematological patient: Risk factors and outcome 73
Totale 2.826
Categoria #
all - tutte 12.354
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.354


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 5 0
2021/2022117 2 0 2 7 6 6 1 14 16 9 20 34
2022/2023384 45 43 24 61 32 44 27 31 44 9 18 6
2023/2024295 12 56 25 19 12 67 30 1 5 10 20 38
2024/2025698 15 8 37 37 45 10 41 27 120 102 147 109
2025/20261.283 218 25 89 169 225 89 233 74 74 87 0 0
Totale 2.826